Chan Mitchell 4
4 · REGENXBIO Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Chan Mitchell
Chief Financial Officer
Transactions
- Award
Stock Options (Right to buy)
2025-01-02+62,547→ 62,547 totalExercise: $7.86Exp: 2035-01-02→ Common Stock (62,547 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer.